AU7383994A - Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases - Google Patents
Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseasesInfo
- Publication number
- AU7383994A AU7383994A AU73839/94A AU7383994A AU7383994A AU 7383994 A AU7383994 A AU 7383994A AU 73839/94 A AU73839/94 A AU 73839/94A AU 7383994 A AU7383994 A AU 7383994A AU 7383994 A AU7383994 A AU 7383994A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- inflammatory diseases
- medicaments containing
- vapiprost
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- ZYOBZRTZRQKKNC-UGNABIHOSA-N (z)-7-[(1r,2r,3s,5s)-3-hydroxy-5-[(4-phenylphenyl)methoxy]-2-piperidin-1-ylcyclopentyl]hept-4-enoic acid;hydrochloride Chemical compound Cl.O([C@H]1C[C@@H]([C@@H]([C@H]1CC\C=C/CCC(O)=O)N1CCCCC1)O)CC(C=C1)=CC=C1C1=CC=CC=C1 ZYOBZRTZRQKKNC-UGNABIHOSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9313649 | 1993-07-01 | ||
| GB939313649A GB9313649D0 (en) | 1993-07-01 | 1993-07-01 | Medicaments |
| PCT/EP1994/002105 WO1995001177A1 (en) | 1993-07-01 | 1994-06-29 | Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7383994A true AU7383994A (en) | 1995-01-24 |
Family
ID=10738145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU73839/94A Abandoned AU7383994A (en) | 1993-07-01 | 1994-06-29 | Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU7383994A (en) |
| GB (1) | GB9313649D0 (en) |
| IL (1) | IL110169A0 (en) |
| WO (1) | WO1995001177A1 (en) |
| ZA (1) | ZA944671B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5662682B2 (en) | 2007-01-18 | 2015-02-04 | エヴォルヴァ エスアー | Substituted 1,3-dioxanes useful as PPAR modulators |
| BRPI0806686A2 (en) | 2007-01-18 | 2014-11-04 | Evolva Sa | COMPOUNDS AND ITS USES, METHODS OF TREATMENT OR PREVENTION, PHARMACEUTICAL COMPOSITIONS AND CRYSTALLINE COMPOUND AND SOLVAT |
| WO2011057262A2 (en) * | 2009-11-09 | 2011-05-12 | Evolva Inc. | Treatment of infections with tp receptor antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA911453B (en) * | 1990-03-19 | 1991-11-27 | Squibb & Sons Inc | Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation |
-
1993
- 1993-07-01 GB GB939313649A patent/GB9313649D0/en active Pending
-
1994
- 1994-06-29 AU AU73839/94A patent/AU7383994A/en not_active Abandoned
- 1994-06-29 ZA ZA944671A patent/ZA944671B/en unknown
- 1994-06-29 WO PCT/EP1994/002105 patent/WO1995001177A1/en not_active Ceased
- 1994-06-30 IL IL11016994A patent/IL110169A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9313649D0 (en) | 1993-08-18 |
| IL110169A0 (en) | 1994-10-07 |
| ZA944671B (en) | 1995-01-16 |
| WO1995001177A1 (en) | 1995-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7545594A (en) | Implantable device for the treatment of aedemas | |
| AU3201095A (en) | Substituted thiazoles for the treatment of inflammation | |
| AU7867994A (en) | Hemofiltration of mediator-related diseases | |
| IL112029A (en) | Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin | |
| AU6623894A (en) | Therapeutic compounds | |
| EP0789592A4 (en) | Ocular gene therapy | |
| AU7931194A (en) | Apparatus for treatment of the oral cavity | |
| AU2805195A (en) | Therapeutic compounds | |
| AU4048295A (en) | Peptide medicaments for the treatment of disease | |
| AU4069095A (en) | Medicaments for the treatment of restenosis and arterial sclerosis | |
| AU4517893A (en) | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use | |
| AU6092794A (en) | Oxime-substituted therapeutic compounds | |
| NZ283957A (en) | Benzamide-containing medicaments suitable for treating neurodegenerative diseases | |
| AU2806692A (en) | Medicament for the treatment of anxiety | |
| AU9173191A (en) | Medicaments for the treatment of papillomavirus diseases | |
| AU3187595A (en) | Compounds for the treatment of restenosis | |
| AU1116895A (en) | Use of theophylline for the manufacture of a medicament for the treatment of asthma | |
| EP0765661A3 (en) | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis | |
| AU3684395A (en) | Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases | |
| EP0689839A3 (en) | Use of inhibitors of adenosine triphosphatase for the manufacture of a medicament for the treatment of disorders anociated with beta-amyloid peptide | |
| AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
| AU4081393A (en) | Medicaments for the treatment of anxiety | |
| AU5627796A (en) | Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury | |
| AU3574793A (en) | Remedy for airway diseases | |
| AU7383994A (en) | Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases |